| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/09/2000 | EP0977777A1 A novel th2-specific gene |
| 02/09/2000 | EP0977764A1 Method for generating saccharide fragments |
| 02/09/2000 | EP0977595A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
| 02/09/2000 | EP0977591A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 02/09/2000 | EP0977590A1 Human monoclonal antibodies |
| 02/09/2000 | EP0977589A1 Adjuvant compositions for vaccines |
| 02/09/2000 | EP0977588A2 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 02/09/2000 | EP0977587A1 Chimeric flavivirus vaccines |
| 02/09/2000 | EP0977586A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | EP0610260B1 Vaccines for actinobacillus pleuropneumoniae |
| 02/09/2000 | EP0560776B1 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses |
| 02/09/2000 | EP0531407B1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 02/09/2000 | EP0487610B1 Prohormone cleavage site blocking antibody |
| 02/09/2000 | CN1244203A 抗原 Antigen |
| 02/09/2000 | CN1244130A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1244126A Universal T-cell epitopes for anti-malarial vaccines |
| 02/09/2000 | CN1243752A Freeze-dried attenuated living vaccine of hepatitis A |
| 02/09/2000 | CN1243751A Method for induction of immunity against virus |
| 02/09/2000 | CN1243716A Medicine for preventing and curing malignant tumor |
| 02/09/2000 | CN1243711A Process for preparing deer products containing disease-resistant factor by immunization |
| 02/09/2000 | CN1049223C Improved meninggococcal polysaccharide conjugate vaccine |
| 02/09/2000 | CN1049118C High special transfer factor preparing process for B type hepatitis |
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022864 Nucleic acid respiratory syncytial virus vaccines |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022745 Homologously recombinant slow growing mycobacteria and uses therefor |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022728 Method for producing a bacterial vaccine and novel vaccines produced thereby |
| 02/08/2000 | US6022726 Genetically engineered attenuated viruses |
| 02/08/2000 | US6022710 Polynucleotide sequence coding a bacterial transcription factor; for the accurate diagnosis, treatment and prevention of bacterial infection; bactericides |
| 02/08/2000 | US6022706 Div1b |
| 02/08/2000 | US6022697 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 02/08/2000 | US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential |
| 02/08/2000 | US6022685 Methods and compositions for detecting anti-hepatitis E virus activity |
| 02/08/2000 | US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 02/08/2000 | US6022544 Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
| 02/08/2000 | US6022543 Hepatitis B surface antigen vaccine |
| 02/08/2000 | US6022542 Polypeptide which serves as reagent in diagnostic kit for detecting an anti-herpesvirus antibody present in a biological sample; kaposi's sarcoma (ks) and retroperitoneal fibromatosis (rf) |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/08/2000 | CA2004206C Method for preparing pertussis toxin toxoid |
| 02/08/2000 | CA2003794C Expression of hiv proteins in drosophila cells |
| 02/03/2000 | WO2000005380A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 02/03/2000 | WO2000005378A2 Streptococcus suis vaccines and diagnostic tests |
| 02/03/2000 | WO2000005372A1 Human ion transport-like protein |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005347A2 Hepatitis b culture system |
| 02/03/2000 | WO2000005268A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | WO2000005266A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | WO2000005265A2 Anti-crr2 antibodies and methods of use therefor |
| 02/03/2000 | WO2000005253A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | WO2000005252A1 Vaccine comprising a non-toxic immunogenic derivative of clostridium botulinum type d neurotoxin |
| 02/03/2000 | WO2000005250A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005240A1 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL46 |
| 02/03/2000 | WO2000004927A1 Allogeneic cellular immunogens useful as cancer vaccines |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004922A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | WO2000004921A1 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine |
| 02/03/2000 | WO2000004920A2 Method of vaccination of newly hatched poultry |
| 02/03/2000 | WO2000004919A2 Live attenuated salmonella vaccines to control avian pathogens |
| 02/03/2000 | WO2000004918A2 Agents for the immunotherapy of tumoral diseases |
| 02/03/2000 | WO2000004917A2 USE OF HC gp-39 IN IMMUNE DISEASES |
| 02/03/2000 | WO1999065517A3 Therapeutic compositions that produce an immune response by altering the antigen |
| 02/03/2000 | WO1999064602A3 Moraxella catarrhalis polynucleotides and polypeptides |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999064448A3 Moraxella catarrhalis pilq proteins |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
| 02/03/2000 | WO1999061049A3 Model for infection by a pathogen using administration of nucleic acids |
| 02/03/2000 | WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 02/03/2000 | WO1999058145A3 Immunomodulators for vaccines |
| 02/03/2000 | WO1999057277A3 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/03/2000 | WO1999057142A3 Vaccine for $i(pseudomonas aeruginosa) |
| 02/03/2000 | WO1999056772A3 Hepatitis vaccine |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/03/2000 | WO1999051263A3 Methods and modified cells for the treatment of cancer |
| 02/03/2000 | WO1999037783A3 Live vaccine against brucellosis |
| 02/03/2000 | DE19836090A1 Avian vitelline antibody directed against soil urease useful for quantifying urease in the soil by immunoassay |
| 02/03/2000 | DE19836084A1 Avian vitelline antibody against ammonifying microorganisms, especially soil bacterium W7/15, useful for quantifying ammonifying microorganisms in the soil by immunoassay |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2714833A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | CA2339045A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | CA2338561A1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | CA2338555A1 Live attenuated salmonella vaccines to control avian pathogens |
| 02/03/2000 | CA2337688A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | CA2336250A1 Anti-ccr2 antibodies and methods of use therefor |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2335345A1 Human calcium regulatory proteins |
| 02/03/2000 | CA2334047A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | CA2334042A1 Orphan cytokine receptor |
| 02/02/2000 | EP0976403A1 Adjuvant comprising pulmonary surfactant |
| 02/02/2000 | EP0976402A2 Vaccines for prevention of gram-negative bacterial infections and endotoxin-related diseases |